Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 7;16(5):e59786.
doi: 10.7759/cureus.59786. eCollection 2024 May.

An Insightful Observation Leading to a Late Diagnosis of Spinal Muscular Atrophy: A Case Report

Affiliations
Case Reports

An Insightful Observation Leading to a Late Diagnosis of Spinal Muscular Atrophy: A Case Report

Felix Rivera Troia et al. Cureus. .

Abstract

Spinal muscular atrophy (SMA) is a rare autosomal recessive neuromuscular disorder characterized by the loss of motor neurons in the spinal cord that results in progressive muscle weakness and atrophy. Most often, the gene involved in this disorder is the survival motor neuron (SMN1) gene, located on the telomeric regions of chromosome 5q13. This gene is involved in the processing of pre-mRNA required for the formation of dendrites and axons. Here we present the case of a 47-year-old female with an extensive past medical history of progressive muscle weakness who, after numerous specialist evaluations, was sent for germline mutation panel sequencing and analysis and was incidentally found to have a pathogenic heterozygous deletion encompassing the exon 8 region of the SMN1 gene. This case report aims to highlight the importance of timely identification and management for individuals who present with early clinical signs of the disease to reduce the morbidity and mortality associated with it.

Keywords: late diagnosis; neuromuscular diseases; smn1 gene; spinal muscular atrophy (sma); survival motor neuron gene.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

References

    1. Spinal muscular atrophy with severe hyperlordosis: a case report. Sharma P, Lohiya S, Vagha K, Vagha JD, Raj H, Prasad R. Cureus. 2024;16:0. - PMC - PubMed
    1. Spinal muscular atrophy: the past, present, and future of diagnosis and treatment. Nishio H, Niba ET, Saito T, Okamoto K, Takeshima Y, Awano H. Int J Mol Sci. 2023;24:11939. - PMC - PubMed
    1. Identifying clinical and genetic characteristics of spinal muscular atrophy patients and families in Saudi Arabia. Alghamdi A, AlDossary S, Abdulaziz Alabdulqader W, Amer F, Ali M, Almomen M, Alghamdi F. Cureus. 2023;15:0. - PMC - PubMed
    1. Spinal muscular atrophy (SMA) [ Apr; 2024 ]. https://www.childrenshospital.org/conditions/spinal-muscular-atrophy-sma https://www.childrenshospital.org/conditions/spinal-muscular-atrophy-sma - PubMed
    1. Spinal muscular atrophy type I associated with a novel SMN1 splicing variant that disrupts the expression of the functional transcript. Votsi C, Koutsou P, Ververis A, Georghiou A, Nicolaou P, Tanteles G, Christodoulou K. Front Neurol. 2023;14:1241195. - PMC - PubMed

Publication types

LinkOut - more resources